Your session is about to expire
← Back to Search
Liver Incytes System for Non-alcoholic Fatty Liver Disease
Study Summary
This trialcompares different non-invasive techniques to measure stiffness in the liver, to find the most effective way.
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Liver Fibrosis
- Non-alcoholic Fatty Liver Disease
- Fatty Liver
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is senior-aged individuals being accepted into this clinical trial?
"Per the trial's criteria for eligibility, individuals must be between 19 and 75 years of age to qualify."
Is enrollment still ongoing for this experiment?
"At present, clinicaltrials.gov does not list this study as actively recruiting participants. Initially posted on October 21st 2020, the listing was last updated December 7th 2022. Despite being closed for recruitment at this time, there are currently 773 other trials open to patient enrollment."
What is the primary purpose of this clinical experiment?
"According to Sonic Incytes, the principal aim of this 12-month clinical trial is assessing Liver Incytes' diagnostic ability in regards to fibrosis staging. Furthermore, secondary objectives include ascertaining the occurrence and technical issues with devices; establishing whether attenuation measurements from MRI Proton Density Fat Fraction and Liver Incytes System are comparable using a concordance correlation coefficient and 95% confidence intervals; as well as comparing FibroScan's elasticity (kPa) readings with those collected by Liver Incyte’s system against Magnetic Resonance Elastography (MRE) results for constructing Receiver Operating Curves"
Is there a possibility of my participation in this clinical research?
"For this research study, volunteers need to be between 19 and 75 years old with a diagnosis of fibrosis. A total of 164 participants are being recruited for the trial."
Share this study with friends
Copy Link
Messenger